%0 Journal Article
%T Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
%J Archive of "Caspian Journal of Internal Medicine".
%D 2019
%R 10.22088/cjim.10.1.7
%X Lymphangioleiomyomatosis (LAM) is a progressive lungs disease that affects women at reproductive years. Sirolimus inhibits mammalian target of rapamycin (mTOR) and its administration in past studies was hopeful in treatment of patients with LAM. The aim of this study was to evaluate sirolimus therapy on lung function in LAM patients
%K Sirolimus
%K Lymphangioleiomyomatosis
%K Lung function
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386328/